---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-047999"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2024-11-27T23:59:59+00:00"
generated_at: "2026-05-29T17:25:02.927630+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech adopts Cash Conservation Plan; independent directors paid entirely in stock

## Summary
- Independent directors will receive 100% of board compensation in shares, effective immediately; no cash compensation.
- Twice-monthly stock grants valued at closing price on last trading day before grant.
- Previously announced CEO Thomas Equels and COO Peter Rodino agreed to reduce cash salaries by $200k and $50k, effective Sept 11, 2024.
- Company encourages shareholders to vote for incumbent directors at Dec 17, 2024 annual meeting on WHITE proxy card.

## SEC filing metadata
- accession: 0001493152-24-047999
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2024-11-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315224047999/0001493152-24-047999-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315224047999/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-047999
- JSON: https://secwatch.observer/filing/0001493152-24-047999.json
- Plain text: https://secwatch.observer/filing/0001493152-24-047999.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.